WO2015199406A1 - L-트립토판 생산능을 갖는 에스케리키아속 미생물 및 이를 이용한 l-트립토판의 제조 방법 - Google Patents
L-트립토판 생산능을 갖는 에스케리키아속 미생물 및 이를 이용한 l-트립토판의 제조 방법 Download PDFInfo
- Publication number
- WO2015199406A1 WO2015199406A1 PCT/KR2015/006350 KR2015006350W WO2015199406A1 WO 2015199406 A1 WO2015199406 A1 WO 2015199406A1 KR 2015006350 W KR2015006350 W KR 2015006350W WO 2015199406 A1 WO2015199406 A1 WO 2015199406A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tryptophan
- gene
- microorganism
- escherichia
- production capacity
- Prior art date
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title claims abstract description 101
- 244000005700 microbiome Species 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 39
- 241000488157 Escherichia sp. Species 0.000 title abstract 4
- 229960004799 tryptophan Drugs 0.000 claims abstract description 65
- 230000000694 effects Effects 0.000 claims abstract description 32
- 108010038136 phospho-2-keto-3-deoxy-gluconate aldolase Proteins 0.000 claims abstract description 14
- 102000004567 6-phosphogluconate dehydrogenase Human genes 0.000 claims abstract description 12
- 108020001657 6-phosphogluconate dehydrogenase Proteins 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 70
- 241000588722 Escherichia Species 0.000 claims description 18
- 150000001413 amino acids Chemical group 0.000 claims description 12
- 101150023849 pheA gene Proteins 0.000 claims description 11
- 101150006320 trpR gene Proteins 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 101150012186 mtr gene Proteins 0.000 claims description 9
- 101150053890 EDA gene Proteins 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 4
- 108010022393 phosphogluconate dehydratase Proteins 0.000 claims description 3
- 230000003313 weakening effect Effects 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 description 41
- 108090000790 Enzymes Proteins 0.000 description 41
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 32
- 238000000034 method Methods 0.000 description 32
- 239000012634 fragment Substances 0.000 description 21
- 239000013598 vector Substances 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 14
- 230000035772 mutation Effects 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 210000000349 chromosome Anatomy 0.000 description 8
- 230000002779 inactivation Effects 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 108091033319 polynucleotide Proteins 0.000 description 8
- 102000040430 polynucleotide Human genes 0.000 description 8
- 239000002157 polynucleotide Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 7
- 229960005091 chloramphenicol Drugs 0.000 description 7
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 230000004619 Entner-Doudoroff pathway Effects 0.000 description 5
- 101150090240 edd gene Proteins 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 230000004941 influx Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000013379 molasses Nutrition 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 150000008575 L-amino acids Chemical class 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- -1 aromatic L-amino acid Chemical class 0.000 description 3
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940107700 pyruvic acid Drugs 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 2
- BIRSGZKFKXLSJQ-SQOUGZDYSA-N 6-Phospho-D-gluconate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O BIRSGZKFKXLSJQ-SQOUGZDYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 2
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 102000003673 Symporters Human genes 0.000 description 2
- 108090000088 Symporters Proteins 0.000 description 2
- 101150107914 Ubr5 gene Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000006109 methionine Nutrition 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- FPWMCUPFBRFMLH-UHFFFAOYSA-N prephenic acid Chemical compound OC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 101150099895 tnaA gene Proteins 0.000 description 2
- 101150037435 tnaB gene Proteins 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 108700026220 vif Genes Proteins 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 1
- PYXDZWUIPFCTJP-XFNAGHOKSA-N (2s)-2-azanyl-3-(1h-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 PYXDZWUIPFCTJP-XFNAGHOKSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- OVPRPPOVAXRCED-WVZVXSGGSA-N 2-dehydro-3-deoxy-6-phospho-D-gluconic acid Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)CC(=O)C(O)=O OVPRPPOVAXRCED-WVZVXSGGSA-N 0.000 description 1
- PQGCEDQWHSBAJP-TXICZTDVSA-N 5-O-phosphono-alpha-D-ribofuranosyl diphosphate Chemical compound O[C@H]1[C@@H](O)[C@@H](O[P@](O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O PQGCEDQWHSBAJP-TXICZTDVSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102100025169 Max-binding protein MNT Human genes 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101800000628 PDH precursor-related peptide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 description 1
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- WTFXTQVDAKGDEY-HTQZYQBOSA-N chorismic acid Chemical compound O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 108091006107 transcriptional repressors Proteins 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 101150044170 trpE gene Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/227—Tryptophan
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/02—Aldehyde-lyases (4.1.2)
- C12Y401/02014—2-Dehydro-3-deoxy-phosphogluconate aldolase (4.1.2.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01012—Phosphogluconate dehydratase (4.2.1.12)
Definitions
- the present invention relates to an Escherichia genus microorganism having L-tryptophan production ability, and a method for producing L-tryptophan using the microorganism.
- L-tryptophan is one of the essential amino acids has been widely used as feed additives, etc., and also has been widely used as pharmaceutical raw materials and health food materials such as infusion solution. As such, L-tryptophan may be produced through chemical synthesis, enzyme reaction, fermentation, etc., but direct fermentation using microorganisms is currently used.
- L-tryptophan-producing strains Development of L-tryptophan-producing strains is initially carried out by mutation screening (Korean Patent No. 1987-0001813), or with the development of genetic engineering to overcome tryptophan feedback inhibition of biosynthetic pathway enzymes, or tryptophan biosynthesis enzymes.
- the development of tryptophan-producing strains was carried out through enhanced enzyme synthesis of metabolic processes, such as enhanced expression.
- the US patent relates to a method for enhancing the production of L-amino acids produced by a biosynthetic pathway using pyruvic acid as an intermediate by enhancing the activity of enzymes involved in the Entner-Doudoroff pathway, specifically 6-phospho It is a key feature to enhance the activity of gluconate dehydrogenase or 2-keto-3-deoxy-6-phosphogluconate aldolase.
- the present invention relates to the Escherichia spp. Microorganism having improved L-tryptophan production capacity and a method for producing L-tryptophan using the same. It was completed.
- An object of the present invention is to provide a microorganism having L-tryptophan production capacity.
- Another object of the present invention is to provide a method for efficiently producing L-tryptophan using a microorganism having the L-tryptophan production ability.
- the present invention provides Escherichia microorganisms having L-tryptophan production ability by attenuating or inactivating 6-phosphogluconate dehydrogenase and 2-keto-3-deoxy-6-phosphogluconate aldolase. By providing this, L-tryptophan can be used to produce a higher yield efficiently and economically.
- the present invention is a weakened or inactivated activity of the intrinsic 6-phosphogluconate dehydrogenase and 2-keto-3-deoxy-6-phosphogluconate aldolase, Provided is an Escherichia microorganism having L-tryptophan production ability.
- L-tryptophan refers to an aromatic L-amino acid having one of ⁇ -amino acids and an essential amino acid not synthesized in the body and having a chemical formula of C 11 H 12 N 2 O 2 .
- Entner-Doudoroff pathway is one of the carbon metabolic pathways present in the Escherichia microorganism, and the carbon source introduced into the pathway is 6-phosphogluconate dehydrogenase and 2-keto-3. Catalyzes the conversion to glyceraldehyde-3-phosphate and pyruvate through a two-step series of enzymatic reactions with deoxy-6-phosphogluconate aldolase. Path.
- 6-phosphogluconate dehydratase (Edd; EC 4.2.1.12) is an enzyme involved in the Entner-Doudoroff pathway, 6-phospho-D-gluconate Means an enzyme catalyzing the reaction of converting to 2-dihydro-3-deoxy-6-phospho-D-gluconate.
- the enzyme may be specifically represented by the amino acid sequence of SEQ ID NO: 1, without limitation, any sequence having the activity of the enzyme is included.
- the gene encoding the 6-phosphogluconate dehydrogenase may be represented by a nucleotide sequence of SEQ ID NO: 2, but is included without limitation as long as the sequence capable of encoding the enzyme.
- the term "2-keto-3-deoxy-6-phosphogluconate aldolase; Eda; EC 4.1.2.14) means Entner.
- an enzyme involved in the -Doudoroff pathway it refers to an enzyme that catalyzes the reaction of converting 2-dihydro-3-deoxy-6-phospho-D-gluconate into glyceraldehyde-3-phosphate and pyruvic acid.
- the enzyme may be specifically represented by the amino acid sequence of SEQ ID NO: 3, and any sequence having the activity of the enzyme is included without limitation.
- the gene encoding the 2-keto-3-deoxy-6-phosphogluconate aldolase may be represented by a nucleotide sequence of SEQ ID NO: 4 as a specific example, without limitation, as long as the sequence can encode the enzyme Included.
- Each of the enzymes is 70% or more, specifically 80% or more, more specifically 90% or more, even more specifically 95% or more, as well as the amino acid sequence set forth in SEQ ID NO: 1 or 3 above. Specifically, any amino acid sequence showing at least 98%, even more specifically, at least 99% homology, and any enzyme having substantially the same or equivalent potency as each of the above enzymes is included without limitation. In addition, as long as it is an amino acid sequence having such homology and exhibiting efficacy corresponding to each enzyme, it is obvious that enzyme variants having amino acid sequences in which some sequences are deleted, modified, substituted or added are also included within the scope of the present invention.
- each of the enzymes is not only the nucleotide sequence set forth in SEQ ID NO: 2 or 4, but also 80% or more, specifically 90% or more, more specifically 95% or more, more specifically A base sequence showing at least 98%, more specifically, at least 99% homology, without limitation, includes a gene sequence encoding an enzyme having substantially the same or equivalent potency as each of the above enzymes.
- the base sequence having such homology it is obvious that the base sequence in which some sequences are deleted, modified, substituted or added is also included in the scope of the present invention.
- homology refers to the percent identity between two polynucleotide or polypeptide moieties. Homology between sequences from one moiety to another may be determined by known techniques. For example, homology may be sequence information between two polynucleotide molecules or two polypeptide molecules, such as score, identity, and similarity, using a computer program that aligns the sequence information and is readily available. Parameters can be determined by direct alignment (eg BLAST 2.0). In addition, homology between polynucleotides can be determined by hybridization of polynucleotides under conditions of stable double-stranding between homologous regions, followed by digestion with single-strand-specific nucleases to determine the size of the digested fragments.
- intrinsic activity refers to the active state of an enzyme that a microorganism possesses in its natural state or before modification of the enzyme.
- the "enzyme activity is weakened compared to the intrinsic activity” means that the activity of the original microorganisms compared to the activity of the enzyme possessed in the natural state or the state before the modification is reduced.
- the weakening is due to mutation of the gene encoding the enzyme and the activity of the enzyme itself is reduced compared to the activity of the enzyme originally possessed by the microorganism, and the inhibition of expression or translation of the gene encoding the same in the cell. If the overall degree of enzymatic activity is low compared to the native strain or the strain before modification, the concept also includes a combination thereof.
- activation refers to a case in which the expression of the gene encoding the enzyme is not expressed at all as compared to the natural type strain or the strain before modification, and a case in which the expression is inactivated.
- Attenuation or inactivation of such enzymatic activity can be achieved by the application of various methods well known in the art.
- the method include a method of replacing a gene encoding the enzyme on a chromosome with a mutated gene such that the activity of the enzyme is reduced, including when the activity of the enzyme is removed; Introducing a mutation into an expression control sequence of a gene on a chromosome encoding said enzyme; Replacing the expression control sequence of the gene encoding the enzyme with a sequence having weak or no activity; Deleting all or part of a gene on a chromosome that encodes the enzyme; Introducing an antisense oligonucleotide (eg, antisense RNA) that complementarily binds to a transcript of a gene on the chromosome to inhibit translation from the mRNA to an enzyme; The method of artificially adding a sequence complementary to the SD sequence in front of the SD sequence of the gene encoding the enzyme to form a secondary structure to make the attachment of
- a method for deleting part or all of a gene encoding an enzyme replaces a polynucleotide encoding an endogenous target protein in a chromosome with a polynucleotide or marker gene in which some nucleic acid sequences are deleted through a bacterial chromosome insertion vector. This can be done by.
- a method of deleting part or all of such genes a method of deleting genes by homologous recombination may be used.
- part may vary depending on the type of polynucleotide, but may be specifically 1 to 300, specifically 1 to 100, and more specifically 1 to 50, but is not particularly limited thereto.
- homologous recombination refers to genetic recombination occurring through linkage exchange at the locus of gene chains having homology with each other.
- the method of modifying an expression control sequence is carried out by inducing a mutation in the expression control sequence by deletion, insertion, non-conservative or conservative substitution, or a combination thereof, in the nucleic acid sequence of the expression control sequence, or by replacement with a weaker promoter. It may be carried out by a method such as.
- the expression control sequence includes a promoter, an operator sequence, a sequence encoding a ribosomal binding site, and a sequence that controls the termination of transcription and translation.
- a method of modifying a gene sequence on a chromosome may be performed by inducing a mutation in the sequence by deletion, insertion, non-conservative or conservative substitution, or a combination thereof, to further weaken the activity of the enzyme, or by performing weaker activity. It can be carried out by replacing with a gene sequence that has been improved to have or a gene sequence that has been improved so that there is no activity.
- the attenuation or inactivation of the activity encodes the gene encoding the 6-phosphogluconate dehydrogenase and 2-keto-3-deoxy-6-phosphogluconate aldolase.
- a transition mutation by insertion of one or more base pairs, a deletion mutation with a deletion of one or more base pairs in the gene, and a base pair that introduces a nonsense codon or a different codon in the gene It has been confirmed that this can be accomplished by one or more mutation methods selected from the group consisting of mutations.
- the Escherichia microorganism may be specifically Escherichia coli , but is not limited thereto.
- Microorganism having L-tryptophan production ability by the weakening or inactivation of the activity of the edd and eda in the present invention is not particularly limited.
- Microorganisms with tryptophan production capacity for example, to attenuate or inactivate the activity of genes of the competitive pathway, modulators of the directional pathway of tryptophan operon, tryptophan influx, tryptophan influx and degradation genes Or microorganisms that overexpress the activity of tryptophan operon.
- the method of weakening or deactivating the activity is as described above, and known methods are included without limitation.
- the overexpression of tryptophan operon activity includes a known method without limitation, for example, a method of additionally inserting a polynucleotide containing an expression control site introduced by itself or externally part or all of the nucleotide sequence of the operon gene to the chromosome , A method of increasing the number of copies by introducing into a vector system, substituting other regulatory sequences for expression control regions that control the expression of genes, modifications in which all or part of the nucleotide sequence of the expression control regions are induced, It may include a method such as enhancing the operon activity by introducing a mutation, but is not limited thereto. Specifically, all or part of the pheA, trpR, mtr and tnaAB genes may be E. coli, which is deleted and / or overexpressed tryptophan operon.
- genes and protein sequences used in the present invention including the edd, eda, pheA, trpR, mtr, tnaAB gene and tryptophan operon and the protein sequences they encode can be obtained from known databases, for example NCBI It can be obtained from GenBank, etc., but is not limited thereto.
- the details of the pheA, trpR, mtr and tnaAB gene can refer to the contents described in Korean Patent Registration No. 10-0792095, the entire specification of the patent may be included as a reference of the present invention.
- Entner results in inactivating the activities of 6-phosphogluconate dehydrogenase and 2-keto-3-deoxy-6-phosphogluconate aldolase in various parent strains.
- 6-phosphogluconate dehydrogenase and 2-keto-3-deoxy-6-phosphogluconate aldolase activity was used regardless of the parent strain.
- the activity of the intrinsic 6-phosphogluconate dehydrogenase and 2-keto-3-deoxy-6-phosphogluconate aldolase of the present invention is weakened or inactivated, Culturing the Escherichia spp. Microorganism having L-tryptophan production capacity; And recovering L-tryptophan from the culture or the microorganism according to the culturing step of the microorganism.
- the medium and other culture conditions used for the cultivation of the microorganism of the present invention may be any medium that is used for the cultivation of ordinary Escherichia microorganisms without particular limitation, but specifically, the microorganism of the present invention may be a suitable carbon source, nitrogen source. It can be cultured under aerobic conditions by adjusting the temperature, pH, etc. in a conventional medium containing the number of people, inorganic compounds, amino acids and / or vitamins.
- the carbon source includes carbohydrates such as glucose, fructose, sucrose, maltose, mannitol, sorbitol and the like; Alcohols such as sugar alcohols, glycerol, pyruvic acid, lactic acid, citric acid and the like; Amino acids such as organic acids, glutamic acid, methionine, lysine and the like.
- natural organic nutrients such as starch hydrolyzate, molasses, blackstrap molasses, rice winters, cassava, sugarcane residue and corn steep liquor can be used, specifically glucose and sterilized pretreated molasses (ie, reducing sugars).
- Carbohydrates, such as molasses), and other appropriate amounts of carbon sources can be used in various ways without limitation. These carbon sources may be used alone or in combination of two or more thereof.
- nitrogen source examples include inorganic nitrogen sources such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, anmonium carbonate, and ammonium nitrate; Organic nitrogen sources such as amino acids such as glutamic acid, methionine, glutamine, etc., peptones, NZ-amines, meat extracts, yeast extracts, malt extracts, corn steep liquor, casein hydrolysates, fish or their degradation products, skim soy cakes or their degradation products Can be used. These nitrogen sources may be used alone or in combination of two or more thereof.
- inorganic nitrogen sources such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, anmonium carbonate, and ammonium nitrate
- Organic nitrogen sources such as amino acids such as glutamic acid, methionine, glutamine, etc., peptones, NZ-amines, meat extracts, yeast extract
- the personnel may include a first potassium phosphate, a second potassium phosphate, or a sodium-containing salt corresponding thereto.
- a first potassium phosphate sodium chloride, calcium chloride, iron chloride, magnesium sulfate, iron sulfate, manganese sulfate, calcium carbonate and the like may be used, and other amino acids, vitamins and / or suitable precursors may be included. These media or precursors may be added batchwise or continuously to the culture.
- compounds such as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid, sulfuric acid and the like can be added to the culture in an appropriate manner to adjust the pH of the culture.
- antifoaming agents such as fatty acid polyglycol esters can be used to suppress bubble generation.
- oxygen or oxygen-containing gas may be injected into the culture, or nitrogen, hydrogen, or carbon dioxide gas may be injected without injecting gas to maintain anaerobic and unaerobic conditions.
- the temperature of the culture may specifically be from 30 ° C to 37 ° C, specifically, 27 ° C to 40 ° C, but is not limited thereto.
- the incubation period may continue until the desired amount of useful material is obtained, specifically, may be 10 hours to 100 hours, but is not limited thereto.
- the recovering L-tryptophan may be carried out using a suitable method known in the art according to the method of culturing the microorganism of the present invention, for example, a batch, continuous or fed-batch culture method, to obtain the desired L-tryptophan from the culture solution. It can be recovered.
- the recovery step may comprise a purification process.
- pKD3 is used as a template, and about 1,100 pairs are obtained by PCR. Gene fragments were amplified. Then, the DNA fragments obtained through the PCR amplification were electrophoresed on a 0.8% agarose gel, eluted, and used as a template for the secondary PCR. Then, in order to obtain 5 'and 3' DNA fragments of the E. coli pheA gene, approximately 250 pairs of gene fragments were respectively generated by PCR using the chromosomes of E.
- E. coli W3110 transformed with pKD46 was prepared as competent cells according to a method developed by Datsenko KA et al., followeded by introducing a 1,600 base pair sized gene fragment obtained by PCR to contain chloramphenicol (30 mg / L). Plated in LB solid medium. The obtained strain was further confirmed that pheA was inactivated with a size of 1,600 base pairs obtained by PCR using primers 3 and 6 to prepare a W3110 ⁇ pheA strain.
- Proteins encoded by trpR having the sequence of SEQ ID NO: 8, mtr having the sequence of SEQ ID NO: 10, tnaAB genes having the sequences of SEQ ID NOs: 12 and 14 were inactivated using the primers of Table 3 below To prepare a W3110 ⁇ pheA ⁇ trpR ⁇ mtr ⁇ tnaAB strain.
- a recombinant vector pCL1920-Ptrc-trpO was prepared by inserting the Ptrc promoter and tryptophan operon gene into the pCL1920 vector.
- a plasmid of pCL1920 was recovered and treated with restriction enzymes HindIII and PstI, and the Ptrc promoter was composed of the pTrcHis B (invitrogen, USA) vector as a template, and primers 23 and 24. It was prepared by the PCR method of repeating the conditions of denaturation at 94 ° C for 30 seconds, annealing at 58 ° C for 30 seconds, and polymerization at 72 ° C for 30 seconds. The prepared Ptrc promoter fragment was digested with restriction enzymes HindIII and PstI, and then ligated with pCL1920 to prepare pCL1920-Ptrc vector.
- the pCL1920_Ptrc_trpO vector was prepared by treatment with PstI and alkaline phosphatase, and the tryptophan operon gene was amplified from chromosomal DNA of E. coli KCCM10812P (Korean Patent No. 10-0792095).
- the first gene of the operon gene, trpE gene has a feedback resistant form.
- PCR was performed by repeating 30 times the conditions of denaturation at 94 ° C for 30 seconds, annealing at 58 ° C for 30 seconds, and polymerization at 72 ° C for 5 minutes using chromosomal DNA of E.
- coli KCCM10812P as a template.
- the obtained DNA fragment was ligated with the pCL1920_Ptrc vector prepared by treatment with PstI, and the resulting vector was named pCL1920_Ptrc_trpO (SEQ ID NO: 15).
- PUCprmfmloxC was used as a template using primers 27 and primers 28 having a part of the edd-eda gene group and some nucleotide sequences of the chloramphenicol resistance gene of the pUCprmfmloxC gene, followed by denaturation at 94 ° C for 30 seconds, annealing at 55 ° C for 30 seconds, and 72 ° C. About 1,200 pairs of gene fragments were amplified by a PCR method that repeated 30 times of polymerization conditions for 1 minute at.
- DNA fragments obtained through PCR amplification were eluted after 0.8% agarose gel electrophoresis and used as a template for the second PCR.
- Secondary PCR had 20 pairs of complementary sequences of the 5 'and 3' regions of the primary DNA fragment, eluting using primers 29 and 30 plus the 5 'and 3' regions of the edd-eda gene family.
- Approximately 1,300 pairs of the gene fragments were amplified by PCR, which was repeated 30 times under conditions of denaturing the prepared primary PCR product at 94 ° C for 30 seconds, annealing at 55 ° C for 30 seconds, and polymerizing at 72 ° C for 1 minute.
- DNA fragments obtained through the above procedure were eluted after 0.8% agarose gel electrophoresis and used for recombination.
- a target E. coli transformed with pKD46 was prepared in a competent state, and then a 1,300 base pair size gene fragment obtained by PCR was introduced and transformed.
- the resulting strains were selected from LB with chloramphenicol resistance, and edd-eda with 1,626 base pairs in size obtained by PCR using primers 31 and 32 again. It was confirmed that the gene group was deleted.
- the primary recombinant strain having chloramphenicol resistance removed pKD46 and then introduced pJW168 to remove the chloramphenicol marker gene from the cells (Gene, (2000) 247, 255-64). Finally, the obtained cells were confirmed to have been deleted as intended with 580 pairs of amplification products obtained by PCR with primers 31 and 32.
- the vector prepared in Comparative Example 1 was introduced and transformed to produce strain W3110 ⁇ pheA ⁇ trpR ⁇ mtr ⁇ tnaAB ⁇ edd ⁇ eda / pCL1920-Ptrc-trpO having tryptophan production capacity.
- the titer was evaluated using the strains prepared in Comparative Example 1 and Example 1. Cells were inoculated with platinum for titer evaluation, then incubated overnight in LB solid medium, and one platinum was inoculated in 25 ml flask titer medium having the composition of Table 1 below. After strain inoculation, the cells were incubated at 37 ° C. and 200 rpm for 42 hours, and the results obtained therefrom are shown in Table 2 below. All results used the average of three flask results.
- the titer was evaluated using the deposited strain KCCM11166P and the strain prepared in Example 3.
- the present inventors confirmed that tryptophan production increased in the inactivated strains of the edd-eda gene group based on the KCCM11166P strain, and named the strain "CA04-2800". KCCM) on November 15, 2013 and was given accession number KCCM11473P.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
조성물 | 농도(리터당) |
글루코스 | 30 g |
K2HPO4 | 1 g |
(NH4)2SO4 | 10 g |
NaCl | 1 g |
MgSO4ㆍ7H2O | 1 g |
구연산나트륨 | 5 g |
효모액기스 | 2 g |
탄산칼슘 | 40 g |
구연산나트륨 | 5 g |
페닐알라닌 | 0.15 g |
타이로신 | 0.1 g |
pH | 6.8 g |
균주 | OD | 소모당 (g/L)* | L-트립토판(g/L)** |
W3110ΔpheAΔtrpRΔmtr ΔtnaAB/pCL1920-Ptrc-trpO | 30.1 | 24.7 | 0.78 |
실시예 1(W3110ΔpheAΔtrpRΔmtrΔtnaABΔeddΔeda/pCL1920-Ptrc-trpO) | 29.5 | 25.1 | 1.03 |
유전자 | 프라이머번호 | 서열 (5'→3') | 서열번호 |
pheA | 1 | AGGCAACACTATGACATCGTGTAGGCTGGAGCTGCTTC | 16 |
2 | GGTCGCCATTAACAACGTGGCATATGAATATCCTCCTTAG | 17 | |
3 | TATTGAGTGTATCGCCAAC | 18 | |
4 | CGATGTCATAGTGTTGCC | 19 | |
5 | CCACGTTGTTAATGGCGACC | 20 | |
6 | TTCATTGAACGGGTGATTTC | 21 | |
trpR | 7 | TCCGCACGTTTATGATATGCTATCGTACTCTTTAGCGAGTACAACCGGGGGTGTAGGCTGGAGCTGCTTC | 22 |
8 | GCCACGTCTTATCAGGCCTACAAAATCAATCGCTTTTCAGCAACACCTCTCATATGAATATCCTCCTTAG | 23 | |
9 | GCGCCGGGCGTATCGACGCA | 24 | |
10 | GCATATCATAAACGTGCGGA | 25 | |
11 | TGTAGGCCTGATAAGACGTG | 26 | |
12 | AAGGGGCGATCGGCGTGTTT | 27 | |
mtr | 13 | ATGGCAACACTAACCACCACCCAAACGTCACCGTCGCTGCTTGGCGGCGTGTGTAGGCTGGAGCTGCTTC | 28 |
14 | TTACTGATACACCGGCAGTAAATTAAAGCTCGATAAAATATGCACCAGTGCATATGAATATCCTCCTTAG | 29 | |
15 | GCAGCCGTTACATTGGTAAC | 30 | |
16 | GTGGTGGTTAGTGTTGCCAT | 31 | |
17 | TACTGCCGGTGTATCAGTAA | 32 | |
18 | TCAAACCGTCAGCACGGCTG | 33 | |
tnaAB | 19 | ATGAAGGATTATGTAATGGAAAACTTTAAACATCTCCCTGAACCGTTCCGGTGTAGGCTGGAGCTGCTTC | 34 |
20 | TTAGCCAAATTTAGGTAACACGTTAAAGACGTTGCCGAACCAGCACAAAACATATGAATATCCTCCTTAG | 35 | |
21 | TTAAGCGAAATCACCGGGGAA | 36 | |
22 | ATGTCCGAGCACTGGCGC | 37 | |
pCL1920-Ptrc-trpO | 23 | CCCAAGCTTGCTGTTGACAATTAATCAT | 38 |
24 | AAAACTGCAGCTGTTTCCTGTGTGAAAT | 39 | |
25 | AAAACTGCAGATGCAAACACAAAAACCGACT | 40 | |
26 | AAAACTGCAGTTAACTGCGCGTCGCCGCTTTC | 41 | |
Edd-eda | 27 | AAACGCGTTGTGAATCATCCTGCTCTGACAACTCAATTTCAGGAGCCTTTGCCGCCAGCTGAAGCTTTAC | 42 |
28 | ACAGCACGCTTTTCAGCGCCAGGTAGTCACGGTAGTTAGCCGGAGAAATATAGTGGATCTGATGGGTACC | 43 | |
29 | TGCCCTATGAGCTCCGGTTACAGGCGTTTCAGTCATAAATCCTCTGAATGAAACGCGTTGTGAATCATCC | 44 | |
30 | ATCGCCCGCTTCCAGCGCATCTGCCGGAACCAGCCAGGAACCACCGATGCACAGCACGCTTTTCAGCGCC | 45 | |
31 | CATGATCTTGCGCAGATTGTA | 46 | |
32 | CATGATCTTGCGCAGATTGTA | 47 |
조성물 | 농도(리터당) |
글루코스 | 60 g |
K2HPO4 | 1 g |
(NH4)2SO4 | 10 g |
NaCl | 1 g |
MgSO4ㆍ7H2O | 1 g |
구연산나트륨 | 5 g |
효모액기스 | 2 g |
탄산칼슘 | 40 g |
구연산나트륨 | 5 g |
페닐알라닌 | 0.15 g |
타이로신 | 0.1 g |
pH | 6.8 g |
균주 | OD | 소모당 (g/L)* | L-트립토판(g/L)** |
KCCM11166P | 22.9 | 31.0 | 5.7 |
KCCM11166PΔeddΔeda | 23.6 | 30.7 | 6.9 |
Claims (6)
- 내재적 6-포스포글루코네이트 탈수소효소(6-phosphogluconate dehydratase; edd) 및 2-케토-3-데옥시-6-포스포글루코네이트 알돌라아제(2-keto-3-deoxy-6-phosphogluconate aldolase; eda)의 활성이 약화 또는 불활성화되는, L-트립토판 생산능을 갖는 에스케리키아속(Escherichia) 미생물.
- 제1항에 있어서, 상기 6-포스포글루코네이트 탈수소효소는 서열번호 1의 아미노산 서열인, L-트립토판 생산능을 갖는 에스케리키아속 미생물.
- 제1항에 있어서, 상기 2-케토-3-데옥시-6-포스포글루코네이트 알돌라아제는 서열번호 3의 아미노산 서열인, L-트립토판 생산능을 갖는 에스케리키아속 미생물.
- 제1항에 있어서, 상기 에스케리키아속 미생물은 대장균(Escherichia coli)인 것인, L-트립토판 생산능을 갖는 에스케리키아속 미생물.
- 제1항에 있어서, 추가로 pheA, trpR, mtr 및 tnaAB 유전자의 전체 또는 일부가 결실된, L-트립토판 생산능을 갖는 에스케리키아속 미생물.
- 제1항 내지 제5항 중 어느 하나의 항의 에스케리키아속 미생물을 배양하는 단계, 및상기 배양에 따른 배양물 또는 상기 미생물로부터 L-트립토판을 회수하는 단계를 포함하는, L-트립토판의 제조 방법.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112016030467-5A BR112016030467B1 (pt) | 2014-06-23 | 2015-06-23 | Microrganismo do gênero escherichia produtor de l-triptofano e método para produzir l-triptofano usando o mesmo |
DK15811391.0T DK3159401T3 (da) | 2014-06-23 | 2015-06-23 | Mikroorganisme af slægten Escherichia, der producerer L-tryptophan, og fremgangsmåde til fremstilling af L-tryptophan under anvendelse af samme |
JP2016575078A JP6687549B2 (ja) | 2014-06-23 | 2015-06-23 | L−トリプトファン生産能を有するエシェリキア属微生物及びこれを用いたl−トリプトファンの製造方法 |
EP15811391.0A EP3159401B1 (en) | 2014-06-23 | 2015-06-23 | Microorganism of the genus escherichia producing l-tryptophan and method for producing l-tryptophan using the same |
ES15811391T ES2918459T3 (es) | 2014-06-23 | 2015-06-23 | Microorganismo del género Escherichia que produce L-triptófano y método para producir L-triptófano mediante el uso del mismo |
CN201580045207.3A CN106574239B (zh) | 2014-06-23 | 2015-06-23 | 生产l-色氨酸的埃希氏菌属微生物和使用其生产l-色氨酸的方法 |
RU2016152662A RU2678139C2 (ru) | 2014-06-23 | 2015-06-23 | Микроорганизм рода Escherichia, продуцирующий L-триптофан, и способ продуцирования L-триптофана с использованием данного микроорганизма |
US15/321,717 US10815510B2 (en) | 2014-06-23 | 2015-06-23 | Microorganism of the genus Escherichia producing L-tryptophan and method for producing L-tryptophan using the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2014-0076698 | 2014-06-23 | ||
KR1020140076698A KR101835173B1 (ko) | 2014-06-23 | 2014-06-23 | L-트립토판 생산능을 갖는 에스케리키아속 미생물 및 이를 이용한 l-트립토판의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015199406A1 true WO2015199406A1 (ko) | 2015-12-30 |
Family
ID=54938423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2015/006350 WO2015199406A1 (ko) | 2014-06-23 | 2015-06-23 | L-트립토판 생산능을 갖는 에스케리키아속 미생물 및 이를 이용한 l-트립토판의 제조 방법 |
Country Status (11)
Country | Link |
---|---|
US (1) | US10815510B2 (ko) |
EP (1) | EP3159401B1 (ko) |
JP (2) | JP6687549B2 (ko) |
KR (1) | KR101835173B1 (ko) |
CN (1) | CN106574239B (ko) |
BR (1) | BR112016030467B1 (ko) |
DK (1) | DK3159401T3 (ko) |
ES (1) | ES2918459T3 (ko) |
MY (1) | MY172369A (ko) |
RU (1) | RU2678139C2 (ko) |
WO (1) | WO2015199406A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019182413A1 (ko) | 2018-03-23 | 2019-09-26 | 씨제이제일제당 (주) | L-아미노산을 포함하는 과립 및 이의 제조방법 |
WO2021007575A1 (en) * | 2019-07-11 | 2021-01-14 | Bp Corporation North America Inc. | Gluconate dehydratase enzymes and recombinant cells |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101996767B1 (ko) * | 2018-11-29 | 2019-07-04 | 씨제이제일제당 (주) | cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법 |
KR102134418B1 (ko) * | 2019-06-17 | 2020-07-16 | 씨제이제일제당 주식회사 | L-타이로신을 생산하는 미생물 및 이를 이용한 l-타이로신 생산 방법 |
CN115261365B (zh) * | 2022-06-22 | 2024-01-30 | 南通紫琅生物医药科技有限公司 | 色氨酸合成酶突变体及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040142435A1 (en) * | 2002-11-20 | 2004-07-22 | Yoshiya Gunji | Method for producing L-amino acid using methylotroph |
US20060115878A1 (en) * | 2002-03-27 | 2006-06-01 | Ajinomoto Co., Inc. | Method for producing L-amino acid |
KR20090092373A (ko) * | 2008-02-27 | 2009-09-01 | 씨제이제일제당 (주) | 피루베이트 옥시다아제가 불활성화된 l-트립토판 생산미생물 및 이를 이용한 l-트립토판 생산 방법 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US913A (en) * | 1838-09-12 | Improved machine for removing snags and sawyers from the beds of rivers | ||
US4371614A (en) * | 1980-08-22 | 1983-02-01 | Ajinomoto Co., Inc. | E.Coli bacteria carrying recombinant plasmids and their use in the fermentative production of L-tryptophan |
US20050191684A1 (en) * | 2004-02-25 | 2005-09-01 | Zimenkov Danila V. | Method for producing L-amino acids |
RU2004105179A (ru) * | 2004-02-25 | 2005-08-10 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) (RU) | 6-фосфоглюконолактоназа из escherichia coli, фрагмент днк, бактерия, принадлежащая к роду escherichia, -продуцент l-аминокислоты, и способ получения l-аминокислоты |
RU2288268C2 (ru) * | 2005-01-26 | 2006-11-27 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) | 6-фосфоглюконолактоназа из escherichia coli, фрагмент днк, бактерия, принадлежащая к роду escherichia - продуцент l-аминокислоты и способ получения l-аминокислоты |
KR101201687B1 (ko) | 2004-02-25 | 2012-11-15 | 아지노모토 가부시키가이샤 | L-아미노산을 생산하는 방법 |
KR100792095B1 (ko) | 2006-12-29 | 2008-01-04 | 씨제이 주식회사 | L-페닐알라닌 생산능을 갖는 대장균 변이주로부터유전자조작된 l-트립토판 생산능을 갖는 재조합 대장균균주 및 이를 이용한 트립토판 제조방법 |
WO2008116853A1 (en) * | 2007-03-23 | 2008-10-02 | Metabolic Explorer | Microorganisms and methods for production of 1,2-propanediol and acetol |
WO2009101757A1 (ja) * | 2008-02-14 | 2009-08-20 | Panasonic Corporation | コンデンサマイクロホン及びmemsデバイス |
DK2803720T3 (da) * | 2012-01-10 | 2022-04-04 | Cj Cheiljedang Corp | Mikroorganismer fra escherichia coli med forbedret produktion af l-tryptofan og fremgangsmåde til fremstilling af l-tryptofan dermed |
-
2014
- 2014-06-23 KR KR1020140076698A patent/KR101835173B1/ko active IP Right Grant
-
2015
- 2015-06-23 DK DK15811391.0T patent/DK3159401T3/da active
- 2015-06-23 CN CN201580045207.3A patent/CN106574239B/zh active Active
- 2015-06-23 US US15/321,717 patent/US10815510B2/en active Active
- 2015-06-23 WO PCT/KR2015/006350 patent/WO2015199406A1/ko active Application Filing
- 2015-06-23 BR BR112016030467-5A patent/BR112016030467B1/pt active IP Right Grant
- 2015-06-23 MY MYPI2016704788A patent/MY172369A/en unknown
- 2015-06-23 RU RU2016152662A patent/RU2678139C2/ru active
- 2015-06-23 EP EP15811391.0A patent/EP3159401B1/en active Active
- 2015-06-23 ES ES15811391T patent/ES2918459T3/es active Active
- 2015-06-23 JP JP2016575078A patent/JP6687549B2/ja active Active
-
2018
- 2018-11-05 JP JP2018207937A patent/JP2019013256A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060115878A1 (en) * | 2002-03-27 | 2006-06-01 | Ajinomoto Co., Inc. | Method for producing L-amino acid |
US20040142435A1 (en) * | 2002-11-20 | 2004-07-22 | Yoshiya Gunji | Method for producing L-amino acid using methylotroph |
KR20090092373A (ko) * | 2008-02-27 | 2009-09-01 | 씨제이제일제당 (주) | 피루베이트 옥시다아제가 불활성화된 l-트립토판 생산미생물 및 이를 이용한 l-트립토판 생산 방법 |
Non-Patent Citations (4)
Title |
---|
BAEZ-VIVEROS, JOSE LUIS ET AL.: "Metabolic transcription analysis of engineered Escherichia coli strains that overproduce L-phenylalanine", MICROBIAL CELL FACTORIES, vol. 6, no. 30, 2007, pages 1 - 20, XP021036410 * |
DATABASE NCBI [O] 28 August 2013 (2013-08-28), "MULTISPECIES: phosphogluconate dehydratase [Proteobacteria]", XP055249440, Database accession no. WP_001069467.1 * |
DATABASE NCBI [O] 28 August 2013 (2013-08-28), XP055249442, Database accession no. WP_000800512.1 * |
See also references of EP3159401A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019182413A1 (ko) | 2018-03-23 | 2019-09-26 | 씨제이제일제당 (주) | L-아미노산을 포함하는 과립 및 이의 제조방법 |
US11370746B2 (en) | 2018-03-23 | 2022-06-28 | Cj Cheiljedang Corporation | Granules comprising L-amino acid and method for preparing the same |
WO2021007575A1 (en) * | 2019-07-11 | 2021-01-14 | Bp Corporation North America Inc. | Gluconate dehydratase enzymes and recombinant cells |
Also Published As
Publication number | Publication date |
---|---|
EP3159401A4 (en) | 2018-01-10 |
ES2918459T3 (es) | 2022-07-15 |
JP2019013256A (ja) | 2019-01-31 |
KR101835173B1 (ko) | 2018-03-07 |
EP3159401B1 (en) | 2022-05-18 |
BR112016030467B1 (pt) | 2023-11-14 |
US20170137854A1 (en) | 2017-05-18 |
BR112016030467A2 (ko) | 2018-01-16 |
EP3159401A1 (en) | 2017-04-26 |
CN106574239A (zh) | 2017-04-19 |
DK3159401T3 (da) | 2022-07-04 |
KR20160000082A (ko) | 2016-01-04 |
US10815510B2 (en) | 2020-10-27 |
RU2678139C2 (ru) | 2019-01-23 |
CN106574239B (zh) | 2024-05-14 |
MY172369A (en) | 2019-11-21 |
JP2017518759A (ja) | 2017-07-13 |
RU2016152662A (ru) | 2018-07-23 |
JP6687549B2 (ja) | 2020-04-22 |
RU2016152662A3 (ko) | 2018-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101261147B1 (ko) | L-아미노산의 생산능이 향상된 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법 | |
WO2013103268A2 (ko) | L-아미노산을 생산할 수 있는 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법 | |
WO2016182322A1 (ko) | L-트립토판 생산능을 갖는 에스케리키아속 미생물 및 이를 이용한 l-트립토판의 제조 방법 | |
WO2013105800A2 (ko) | L-트립토판 생산능이 강화된 에스케리키아속 미생물 및 이를 이용하여 l-트립토판을 생산하는 방법 | |
WO2010093182A2 (ko) | L-아미노산 생산용 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법 | |
WO2013105802A2 (ko) | 자일로즈 이용능이 부여된 코리네박테리움 속 미생물 및 이를 이용한 l-라이신의 생산방법 | |
WO2015199406A1 (ko) | L-트립토판 생산능을 갖는 에스케리키아속 미생물 및 이를 이용한 l-트립토판의 제조 방법 | |
WO2016182321A1 (ko) | L-트립토판 생산능을 갖는 에스케리키아속 미생물 및 이를 이용한 l-트립토판의 제조 방법 | |
WO2017034165A1 (ko) | L-라이신 생산능을 가지는 코리네박테리움 속 미생물 및 이를 이용한 l-라이신 생산방법 | |
WO2016171392A1 (ko) | 글루코네이트 리프레서 변이체, 이를 포함하는 l-라이신을 생산하는 미생물 및 이를 이용한 l-라이신 생산방법 | |
WO2017034164A1 (ko) | L-라이신 생산능을 가지는 코리네박테리움 속 미생물 및 이를 이용한 l-라이신 생산방법 | |
WO2014171747A1 (ko) | L-트립토판 생산능을 갖는 미생물 및 이를 이용하여 l-트립토판을 생산하는 방법 | |
WO2015174655A1 (ko) | L-라이신을 생산하는 코리네박테리움 속 미생물 및 이를 이용한 l-라이신의 생산방법 | |
WO2014126384A1 (ko) | L-쓰레오닌 생산능을 가지는 재조합 에스케리키아 속 미생물 및 이를 이용한 l-쓰레오닌의 생산방법 | |
WO2015122569A1 (ko) | L-쓰레오닌 생산능을 가지는 재조합 에스케리키아 속 미생물 및 이를 이용한 l-쓰레오닌의 생산방법 | |
WO2014175663A1 (ko) | L-아르기닌 생산능이 향상된 코리네박테리움속 미생물 및 이를 이용한 l-아르기닌의 생산 방법 | |
EP3119875A1 (en) | Microorganisms producing l-amino acids and process for producing l-amino acids using the same | |
WO2021085795A1 (ko) | Ansb 유전자 불활성화에 의해 아미노산 생산능력이 향상된 균주 | |
WO2017069567A1 (ko) | L-쓰레오닌을 생산하는 재조합 미생물 및 이를 이용하여 l-쓰레오닌을 생산하는 방법 | |
WO2015186958A1 (ko) | O-숙시닐호모세린 또는 숙신산의 생산능을 갖는 미생물 및 이를 이용한 숙신산 또는 o-숙시닐호모세린의 생산 방법 | |
WO2021085796A1 (ko) | Glsb 유전자 불활성화에 의해 아미노산 생산능력이 향상된 균주 및 이의 제조방법 | |
WO2017065457A1 (ko) | L-쓰레오닌 생산능을 가지는 미생물 및 그를 이용하여 l-쓰레오닌을 생산하는 방법 | |
WO2015142021A1 (en) | Microorganisms having enhanced l-amino acids productivity and process for producing l-amino acids using the same | |
WO2022191358A1 (ko) | L-라이신 생산능이 향상된 코리네박테리움 글루타미쿰 변이주 및 이를 이용한 l-라이신의 생산 방법 | |
WO2022231054A1 (ko) | L-라이신 생산능이 향상된 코리네박테리움 글루타미쿰 변이주 및 이를 이용한 l-라이신의 생산 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15811391 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016575078 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15321717 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112016030467 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2016152662 Country of ref document: RU Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2015811391 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015811391 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 112016030467 Country of ref document: BR Kind code of ref document: A2 Effective date: 20161223 |